Division of Geriatric and Intensive Care Medicine, Referral Centre for Hypertension in Older Adults, University of Florence and Azienda Ospedaliero-Universitaria Careggi, Largo Brambilla 3, 50139, Florence, Italy.
Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
High Blood Press Cardiovasc Prev. 2024 May;31(3):261-269. doi: 10.1007/s40292-024-00639-z. Epub 2024 Apr 24.
Despite high prevalence of hypertension, few studies have analysed the adverse effects (AEs) of antihypertensive medications, especially in older patients.
To investigate the prevalence and associated factors of antihypertensive-related AEs, focusing on the influence of age on treatment tolerability.
We retrospectively investigated antihypertensive-related AEs in patients evaluated at the Hypertension Clinic of Careggi Hospital, Florence, Italy, between January 2017 and July 2020. Multivariable regression models were generated to analyse variables associated with AEs in the overall sample and in participants ≥75 years.
Among 622 subjects (mean age 64.8 years, 51.4% female), the most frequently reported AEs were calcium-channel blockers (CCB)-related ankle swelling (26.8%) and ACEi-induced cough (15.1%). Ankle swelling was more common in older patients (35.7% vs 22.3%, p = 0.001; odds ratio [OR] 1.94, 95%CI 1.289-2.912) and was independently associated with Body Mass Index (BMI, adjOR 1.073) and angiotensin-receptor antagonists (adjOR 1.864). The association with BMI was confirmed in older patients (adjOR 1.134). ACEi-induced cough showed similar prevalence in younger and older patients (13.9% vs 15.6%, p = 0.634), being independently associated with female sex (adjOR 2.118), gastroesophageal reflux disease (GERD, adjOR 2.488) and SNRI therapy (adjOR 8.114). The association with GERD was confirmed in older patients (adjOR 3.238).
CCB-related ankle swelling and ACEi-induced cough represent the most common antihypertensive-related AEs, also at old age. Older patients showed a two-fold increased risk of ankle swelling, that was also independently associated with BMI. ACEi-induced cough had similar prevalence at younger and old ages, being independently associated with GERD.
尽管高血压的患病率很高,但很少有研究分析抗高血压药物的不良反应(AEs),尤其是在老年患者中。
研究抗高血压相关不良反应的患病率及其相关因素,重点关注年龄对抗高血压药物耐受性的影响。
我们回顾性调查了 2017 年 1 月至 2020 年 7 月期间在意大利佛罗伦萨卡雷吉医院高血压诊所就诊的患者的抗高血压相关不良反应。使用多变量回归模型分析了总体样本和≥75 岁患者中与不良反应相关的变量。
在 622 名受试者中(平均年龄 64.8 岁,51.4%为女性),报告最多的不良反应是钙通道阻滞剂(CCB)相关的脚踝肿胀(26.8%)和 ACEi 引起的咳嗽(15.1%)。脚踝肿胀在老年患者中更为常见(35.7%比 22.3%,p=0.001;优势比[OR]1.94,95%CI 1.289-2.912),与体重指数(BMI)和血管紧张素受体拮抗剂(adjOR 1.864)独立相关。BMI 与脚踝肿胀的相关性在老年患者中得到证实(adjOR 1.134)。ACEi 引起的咳嗽在年轻和老年患者中的患病率相似(13.9%比 15.6%,p=0.634),与女性性别(adjOR 2.118)、胃食管反流病(GERD,adjOR 2.488)和 SNRI 治疗(adjOR 8.114)独立相关。在老年患者中,GERD 与 ACEi 引起的咳嗽的相关性得到证实(adjOR 3.238)。
CCB 相关的脚踝肿胀和 ACEi 引起的咳嗽是最常见的抗高血压相关不良反应,在老年患者中也很常见。老年患者脚踝肿胀的风险增加了两倍,且与 BMI 独立相关。ACEi 引起的咳嗽在年轻和老年患者中的患病率相似,与 GERD 独立相关。